National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
NCI Drug Dictionary
Page Options
Print This Page  Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
Contains
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

paclitaxel albumin-stabilized nanoparticle formulation  Patient Information
A Cremophor ELP-free, albumin-stabilized nanoparticle formulation of the natural taxane paclitaxel with antineoplastic activity. Paclitaxel binds to and stabilizes microtubules, preventing their depolymerization and so inhibiting cellular motility, mitosis, and replication. This formulation solubilizes paclitaxel without the use of Cremophor ELP and permits the administration of larger doses of this agent, which would be toxic in a Cremophor ELP-containing formulation due to Cremophor ELP's toxicity profile. Cremophor ELP is a nonionic solubilizer made by reacting castor oil with ethylene oxide in a molar ratio of 1:35, followed by a purification step. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
Synonyms:Albumin-Stabilized Nanoparticle Paclitaxel
nab paclitaxel
nab-paclitaxel
nanoparticle albumin-bound paclitaxel
Nanoparticle Paclitaxel
US brand name:Abraxane
Code name:ABI-007


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov